Insights from Industry Innovators
Carey Powers caught up with five innovative companies at this years OIS XIV in San Diego, to discuss the latest advancements in ophthalmology on the OIS podcast.
Topics included touchless laser therapy for presbyopia, extending the duration of intravitreal treatments, next-generation tear fluid testing, and new imaging methodologies for vitreoretinal conditions. Guests include:
🔹Alex Lopez, Chief Commercial Officer – Ace Vision Group
🔹Houman Hamadi, MD, PhD, Co-Founder & Chief Medical Officer – Optigo Biotherapeutics
🔹Leanne Lavriola, DO, MBA, President & CEO – InnSight Technology
🔹Nir Katchinskiy, PhD, CEO & Co-Founder – PulseMedica
Resources:
Ace Vision Group: https://acevisiongroup.com/
Optigo Biotherapeutics: https://www.optigobio.com/
InnSight Technology: https://www.innsightech.com/
PulseMedica: https://www.pulsemedica.com/
Explore More Articles
The Future of the Aging Eye
AnnMarie Hipsley, the Founder and CEO of Ace Vision Group (AVG), a Delaware, USA- based company developing innovative therapeutics for age-related ocular dysfunctions, talks to The Ophthalmologist about her background and work with AVG, and the company’s short- and long-term goals. She explains how the Group has utilized artificial intelligence and virtual reality platforms to …
Show videoScleral approaches to presbyopia moving from niche to mainstream
Among the many options for presbyopia, scleral approaches stand out for their unique attempt to tackle the roots of the problem, restoring physiological function rather than aiming for optical compensation. They had a slow takeoff and limited acceptance, but step by step, through a long path of research and technological upgrades, they continue to move …
read moreDynamic range of focus recovery in presbyopes after laser scleral microporation
While considered by many to be a “normal process of aging,” the loss of the dynamic focusing function of the eye, presbyopia, is a progressive disease of ocular aging. Presbyopia affects approximately 1.8 billion people globally.1 Estimated global annual productivity losses are approximately 0.037% of the global gross domesticproduct in presbyopic adults less than 65 years …
read more